-
US futures point to a lower open today
-
3M (MMM.US) to provide 35 million facemasks a month
-
Gilead (GILD.US) acquires Forty Seven for $95.50 a share
Global equity markets started the week on a strong footing with Asian indices closing significantly higher on Monday. However, risk-on moods abated during the European trading hours. US futures are down 1% while earlier they traded 2% higher.
Head of US coronavirus task force expects many more cases
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe United States reported two coronavirus-related deaths over the weekend and around 20 new cases. Major point of concern is that cases began to surface in key US cities, like for example New York. It also looks like Seattle may be a site of the first, bigger US coronavirus outbreak. Mike Pence, Vice President of the United States and head of the US coronavirus task force, said that he expects many more coronavirus cases to be reported. Having said that, the situation in the US is likely to get worse. ISM manufacturing release for February (3:00 pm GMT) will offer an insight on the damage. Apart from that, Donald Trump will meet with representatives of major pharmaceutical companies today. The aim of the meeting is to discuss progress on cure development.
Dow Jones (US30) attempted to break above the price zone at 25350 pts today but failed. The index is pulling back below the zone and, in case downbeat moods prevail, may be set to test Friday’s low at around 24800 pts. These two levels should be on watch at the beginning of today’s session. Traders should keep in mind that volatility may jump at 3:00 pm GMT when ISM data is released. Source: xStation5
3M (MMM.US) is one of the US companies attracting increased attention during the ongoing market turmoil. This is because 3M has a “Medical Solutions” business unit that manufacturers, among others, facemasks. The company has earlier hinted that it will boost facemask production due to the outbreak. Mike Pence, US Vice President, said over the weekend that the company will provide 35 million face masks a month.
Twitter (TWTR.US) gains in premarket trade. The move follows Bloomberg report saying that Eliott Management, famous activist investor, has taken a stake in the company. Moreover, Eliott is said to be pushing for a replacement of the Chief Executive Officer, Jack Dorsey. Shares climbed as much as 9% in pre-session trade.
While 3M (MMM.US) is one of the biggest facemask producers in the United States, production of masks is not a major part of its business. Having said that, the stock failed to catch a bid on recent market sell-off. However, the company may attract increased attention today after VP Pence said that it will provide 35 million masks a month. The nearest support for the stock is marked with local lows from 2015 as well as the lower limit of the downward channel ($137.50). Source: xStation5
Gilead Sciences (GILD.US) announced it will buy Forty Seven, the US clinical-stage immuno-oncology company. Gilead will acquire Forty Seven shares for a $95.50/share - 95% above Friday’s closing price. The transaction will be carried out on an all-cash basis and is expected to close in the second quarter of the year. Citi and JPMorgan act as financial advisers to Gilead while Centerview Partners advises Forty Seven.
United Airlines Holdings (UAL.US) confirmed earlier Reuters report. Reuters said that the CEO of United Airlines sent an internal memo to employees saying that the company would likely need to cut more flights. The decision comes as a coronavirus outbreak hit demand for travel.
United Airline Holdings (UAL.DE) slumped recently as the coronavirus outbreak limited demand for travel causing deterioration in the outlook for the airline sector. The stock dropped to the support zone ranging above the 61.8% Fibo level last week. Shares erased over a half of the upward move started in mid-2016 and may be on track for more weakness. In such a scenario, the stock may decline towards the support at 78.6% retracement ($50.50). Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.